Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
K. Bushby(Newcastle University), Carolyn M. Constantin(Centers for Disease Control and Prevention), David J. Birnkrant(MetroHealth Medical Center), Frederic Shapiro(Northeastern University), Linda Cripe(The Ohio State University), Laura E. Case, Craig M. McDonald(University of California Davis Medical Center), Ajay Kaul(Cincinnati Children's Hospital Medical Center), Richard S. Finkel(St. Jude Children's Research Hospital), Paula R. Clemens(University of Pittsburgh), Shree Pandya(University of Rochester Medical Center), Kathi Kinnett(Cincinnati Children's Hospital Medical Center), Jean Tomezsko(Children's Hospital of Philadelphia), James Poysky(Baylor College of Medicine)
Cited by 2,031
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466